Aneuploidy and chromosomal instability: A vicious cycle driving cellular evolution and cancer genome chaos

Cancer and Metastasis Reviews

Volumn 32, Issue 3-4, 2013, Pages 377-389

  Potapova, Tamara A ^a   Zhu, Jin ^a   Li, Rong ^a  

^a STOWERS INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Aneuploidy; Chromosomal instability; Gene dosage; Mitotic checkpoint

Indexed keywords

ANEUPLOIDY; ARTICLE; CELL CYCLE CHECKPOINT; CHROMOSOMAL INSTABILITY; CHROMOSOME SEGREGATION; DNA REPLICATION; EUKARYOTE; GENE DOSAGE; GENOME CHAOS; GENOMIC INSTABILITY; HUMAN; KARYOTYPE; MAMMAL; MITOSIS; NONHUMAN; PRIORITY JOURNAL; STOICHIOMETRY; TELOMERE; YEAST;

ANEUPLOIDY; ANIMALS; CHROMOSOMAL INSTABILITY; CYTOKINESIS; GENE DOSAGE; GENE EXPRESSION REGULATION; HUMANS; MAMMALS; NEOPLASMS; PLANTS; TETRAPLOIDY; YEASTS;

EID: 84890312311     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-013-9436-6     Document Type: Article

References (95)

1. Chimpanzee Sequencing and Analysis Consortium. (2005). Initial sequence of the chimpanzee genome and comparison with the human genome. Nature, 437, 69-87.
2. Dobzhansky, T. (Ed.). (1951). Genetics and the origin of species (3rd ed., pp. 73-118). New York: Columbia University Press.
3. Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell, 144, 646-674.
4. Hanahan, D., & Weinberg, R. A. (2000). The hallmarks of cancer. Cell, 100, 57-70.
5. Anders, K., Kudrna, J., Keller, K., Kinghorn, B., Miller, E., et al. (2009). A strategy for constructing aneuploid yeast strains by transient nondisjunction of a target chromosome. BMC Genetics, 10, 36.
6. Torres, E. M., Sokolsky, T., Tucker, C. M., Chan, L. Y., Boselli, M., et al. (2007). Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science, 317, 916-924.
7. Ezov, T. K., Boger-Nadjar, E., Frenkel, Z., Katsperovski, I., Kemeny, S., et al. (2006). Molecular-genetic biodiversity in a natural population of the yeast Saccharomyces cerevisiae from "Evolution Canyon": microsatellite polymorphism, ploidy and controversial sexual status. Genetics, 174, 1455-1468.
8. Hughes T. R., Roberts C. J., Dai H., Jones A. R., Meyer M. R., et al. (2000). Widespread aneuploidy revealed by DNA microarray expression profiling. Nat Genet, 25, 333-337.
9. Parry, E. M., & Cox, B. S. (1970). The tolerance of aneuploidy in yeast. Genetical Research, 16, 333-340.
10. Campbell, D., Doctor, J. S., Feuersanger, J. H., & Doolittle, M. M. (1981). Differential mitotic stability of yeast disomes derived from triploid meiosis. Genetics, 98, 239-255.
11. Charles, J. S., Hamilton, M. L., & Petes, T. D. (2010). Meiotic chromosome segregation in triploid strains of Saccharomyces cerevisiae. Genetics, 186, 537-550.
12. Pavelka, N., Rancati, G., Zhu, J., Bradford, W. D., Saraf, A., et al. (2010). Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast. Nature, 468, 321-325.
13. Sheltzer, J. M., Blank, H. M., Pfau, S. J., Tange, Y., George, B. M., et al. (2011). Aneuploidy drives genomic instability in yeast. Science, 333, 1026-1030.
14. Waghmare, S. K., & Bruschi, C. V. (2005). Differential chromosome control of ploidy in the yeast Saccharomyces cerevisiae. Yeast, 22, 625-639.
15. Zang, Y., Garrè, M., Gjuracic, K., & Bruschi, C. V. (2002). Chromosome V loss due to centromere knockout or MAD2-deletion is immediately followed by restitution of homozygous diploidy in Saccharomyces cerevisiae. Yeast, 19, 553-564.
16. Zhu, J., Pavelka, N., Bradford, W. D., Rancati, G., & Li, R. (2012). Karyotypic determinants of chromosome instability in aneuploid budding yeast. PLoS Genetics, 8, e1002719.
17. Koncz, C., Chua, N.-H., Schell, J. (1992). Methods in arabidopsis research (pp. 496). Singapore: World Scientific Publishing.
18. Papp, I., Iglesias, V. A., Moscone, E. A., Michalowski, S., Spiker, S., et al. (1996). Structural instability of a transgene locus in tobacco is associated with aneuploidy. The Plant Journal, 10, 469-478.
19. Hernandez, D., & Fisher, E. M. (1999). Mouse autosomal trisomy: two's company, three's a crowd. Trends in Genetics, 15, 241-247.
20. Reish, O., Regev, M., Kanesky, A., Girafi, S., & Mashevich, M. (2011). Sporadic aneuploidy in PHA-stimulated lymphocytes of trisomies 21, 18, and 13. Cytogenetic and Genome Research, 133, 184-189.
21. Reish, O., Brosh, N., Gobazov, R., Rosenblat, M., Libman, V., et al. (2006). Sporadic aneuploidy in PHA-stimulated lymphocytes of Turner's syndrome patients. Chromosome Research, 14, 527-534.
22. Khan, I., Malinge, S., & Crispino, J. (2011). Myeloid leukemia in Down syndrome. Critical Reviews in Oncogenesis, 16, 25-36.
23. Schoemaker, M. J., Swerdlow, A. J., Higgins, C. D., Wright, A. F., & Jacobs, P. A. (2008). Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study. The Lancet Oncology, 9, 239-246.
24. Swerdlow, A. J., Schoemaker, M. J., Higgins, C. D., Wright, A. F., & Jacobs, P. A. (2005). Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study. Journal of the National Cancer Institute, 97, 1204-1210.
25. Higgins, C. D., Swerdlow, A. J., Schoemaker, M. J., Wright, A. F., & Jacobs, P. A. (2007). Mortality and cancer incidence in males with Y polysomy in Britain: a cohort study. Human Genetics, 121, 691-696.
26. Friedberg, E. C., Henning, K., Lambert, C., Saxon, P. J., Schultz, R. A., et al. (1990). Microcell-mediated chromosome transfer: a strategy for studying the genetics and molecular pathology of human hereditary diseases with abnormal responses to DNA damage. Basic Life Sciences, 52, 257-267.
27. Nawata, H., Kashino, G., Tano, K., Daino, K., Shimada, Y., et al. (2011). Dysregulation of gene expression in the artificial human trisomy cells of chromosome 8 associated with transformed cell phenotypes. PLoS One, 6, e25319.
28. Kost-Alimova, M., Fedorova, L., Yang, Y., Klein, G., & Imreh, S. (2004). Microcell-mediated chromosome transfer provides evidence that polysomy promotes structural instability in tumor cell chromosomes through asynchronous replication and breakage within late-replicating regions. Genes, Chromosomes & Cancer, 40, 316-324.
29. Thompson, S. L., & Compton, D. A. (2010). Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. The Journal of Cell Biology, 188, 369-381.
30. Upender, M. B., Habermann, J. K., McShane, L. M., Korn, E. L., Barrett, J. C., et al. (2004). Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells. Cancer Research, 64, 6941-6949.
31. Stingele, S., Stoehr, G., Peplowska, K., Cox, J., Mann, M., et al. (2012). Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells. Molecular Systems Biology, 8, 608.
32. Williams, B. R., Prabhu, V. R., Hunter, K. E., Glazier, C. M., Whittaker, C. A., et al. (2008). Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science, 322, 703-709.
33. Hughes, T. R., Roberts, C. J., Dai, H., Jones, A. R., Meyer, M. R., et al. (2000). Widespread aneuploidy revealed by DNA microarray expression profiling. Nature Genetics, 25, 333-337.
34. Rancati, G., Pavelka, N., Fleharty, B., Noll, A., Trimble, R., et al. (2008). Aneuploidy underlies rapid adaptive evolution of yeast cells deprived of a conserved cytokinesis motor. Cell, 135, 879-893.
35. Mao, R., Zielke, C. L., Zielke, H. R., & Pevsner, J. (2003). Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. Genomics, 81, 457-467.
36. FitzPatrick, D. R., Ramsay, J., McGill, N. I., Shade, M., Carothers, A. D., et al. (2002). Transcriptome analysis of human autosomal trisomy. Human Molecular Genetics, 11, 3249-3256.
37. Ait Yahya-Graison, E., Aubert, J., Dauphinot, L., Rivals, I., Prieur, M., et al. (2007). Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes. American Journal of Human Genetics, 81, 475-491.
38. Torres, E. M., Dephoure, N., Panneerselvam, A., Tucker, C. M., Whittaker, C. A., et al. (2010). Identification of aneuploidy-tolerating mutations. Cell, 143, 71-83.
39. Barnhart, E. L., Dorer, R. K., Murray, A. W., & Schuyler, S. C. (2011). Reduced Mad2 expression keeps relaxed kinetochores from arresting budding yeast in mitosis. Molecular Biology of the Cell, 22, 2448-2457.
40. Musacchio, A., & Salmon, E. D. (2007). The spindle-assembly checkpoint in space and time. Nature Reviews Molecular Cell Biology, 8, 379-393.
41. Iwanaga, Y., Chi, Y. H., Miyazato, A., Sheleg, S., Haller, K., et al. (2007). Heterozygous deletion of mitotic arrest-deficient protein 1 (MAD1) increases the incidence of tumors in mice. Cancer Research, 67, 160-166.
42. Sotillo, R., Schvartzman, J. M., Socci, N. D., & Benezra, R. (2010). Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal. Nature, 464, 436-440.
43. Weaver, B. A., Bonday, Z. Q., Putkey, F. R., Kops, G. J., Silk, A. D., et al. (2003). Centromere-associated protein-E is essential for the mammalian mitotic checkpoint to prevent aneuploidy due to single chromosome loss. The Journal of Cell Biology, 162, 551-563.
44. Baker, D. J., Jin, F., Jeganathan, K. B., & van Deursen, J. M. (2009). Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity. Cancer Cell, 16, 475-486.
45. Hartman, T. K., Wengenack, T. M., Poduslo, J. F., & van Deursen, J. M. (2007). Mutant mice with small amounts of BubR1 display accelerated age-related gliosis. Neurobiology of Aging, 28, 921-927.
46. Baker, D. J., Jeganathan, K. B., Malureanu, L., Perez-Terzic, C., Terzic, A., et al. (2006). Early aging-associated phenotypes in Bub3/Rae1 haploinsufficient mice. The Journal of Cell Biology, 172, 529-540.
47. Storchova, Z., & Kuffer, C. (2008). The consequences of tetraploidy and aneuploidy. Journal of Cell Science, 121, 3859-3866.
48. Ryan, S. D., Britigan, E. M., Zasadil, L. M., Witte, K., Audhya, A., et al. (2012). Up-regulation of the mitotic checkpoint component Mad1 causes chromosomal instability and resistance to microtubule poisons. Proceedings of the National Academy of Sciences of the United States of America, 109, E2205-E2214.
49. Sotillo, R., Hernando, E., Diaz-Rodriguez, E., Teruya-Feldstein, J., Cordon-Cardo, C., et al. (2007). Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell, 11, 9-23.
50. Ricke, R. M., Jeganathan, K. B., & van Deursen, J. M. (2011). Bub1 overexpression induces aneuploidy and tumor formation through Aurora B kinase hyperactivation. The Journal of Cell Biology, 193, 1049-1064.
51. Zhang, N., Ge, G., Meyer, R., Sethi, S., Basu, D., et al. (2008). Overexpression of Separase induces aneuploidy and mammary tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America, 105, 13033-13038.
52. Yu, R., Lu, W., Chen, J., McCabe, C. J., & Melmed, S. (2003). Overexpressed pituitary tumor-transforming gene causes aneuploidy in live human cells. Endocrinology, 144, 4991-4998.
53. Schvartzman, J. M., Duijf, P. H., Sotillo, R., Coker, C., & Benezra, R. (2011). Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell, 19, 701-714.
54. Kabeche, L., & Compton, D. A. (2012). Checkpoint-independent stabilization of kinetochore-microtubule attachments by Mad2 in human cells. Current Biology, 22, 638-644.
55. Ricke, R. M., & van Deursen, J. M. (2011). Aurora B hyperactivation by Bub1 overexpression promotes chromosome missegregation. Cell Cycle, 10, 3645-3651.
56. Bakhoum, S. F., Thompson, S. L., Manning, A. L., & Compton, D. A. (2009). Genome stability is ensured by temporal control of kinetochore- microtubule dynamics. Nature Cell Biology, 11, 27-35.
57. Kline-Smith, S. L., Khodjakov, A., Hergert, P., & Walczak, C. E. (2004). Depletion of centromeric MCAK leads to chromosome congression and segregation defects due to improper kinetochore attachments. Molecular Biology of the Cell, 15, 1146-1159.
58. Janssen, A., van der Burg, M., Szuhai, K., Kops, G. J., & Medema, R. H. (2011). Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science, 333, 1895-1898.
59. Crasta, K., Ganem, N. J., Dagher, R., Lantermann, A. B., Ivanova, E. V., et al. (2012). DNA breaks and chromosome pulverization from errors in mitosis. Nature, 482, 53-58.
60. Stevens, J. B., Liu, G., Bremer, S. W., Ye, K. J., Xu, W., et al. (2007). Mitotic cell death by chromosome fragmentation. Cancer Research, 67, 7686-7694.
61. Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., et al. (2011). Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell, 144, 27-40.
62. Heng, H. H., Stevens, J. B., Bremer, S. W., Liu, G., Abdallah, B. Y., et al. (2011). Evolutionary mechanisms and diversity in cancer. Advances in Cancer Research, 112, 217-253.
63. Normand, G., & King, R. W. (2010). Understanding cytokinesis failure. Advances in Experimental Medicine and Biology, 676, 27-55.
64. Shi, Q., & King, R. W. (2005). Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines. Nature, 437, 1038-1042.
65. Routhier, E. L., Burn, T. C., Abbaszade, I., Summers, M., Albright, C. F., et al. (2001). Human BIN3 complements the F-actin localization defects caused by loss of Hob3p, the fission yeast homolog of Rvs161p. Journal of Biological Chemistry, 276, 21670-21677.
66. Kouranti, I., Sachse, M., Arouche, N., Goud, B., & Echard, A. (2006). Rab35 regulates an endocytic recycling pathway essential for the terminal steps of cytokinesis. Current Biology, 16, 1719-1725.
67. Madaule, P., Eda, M., Watanabe, N., Fujisawa, K., Matsuoka, T., et al. (1998). Role of citron kinase as a target of the small GTPase Rho in cytokinesis. Nature, 394, 491-494.
68. Yuce, O., Piekny, A., & Glotzer, M. (2005). An ECT2-centralspindlin complex regulates the localization and function of RhoA. The Journal of Cell Biology, 170, 571-582.
69. Therman, E., Trunca, C., Kuhn, E. M., & Sarto, G. E. (1986). Dicentric chromosomes and the inactivation of the centromere. Human Genetics, 72, 191-195.
70. Acilan, C., Potter, D. M., & Saunders, W. S. (2007). DNA repair pathways involved in anaphase bridge formation. Genes, Chromosomes & Cancer, 46, 522-531.
71. Steigemann, P., Wurzenberger, C., Schmitz, M. H., Held, M., Guizetti, J., et al. (2009). Aurora B-mediated abscission checkpoint protects against tetraploidization. Cell, 136, 473-484.
72. Nigg, E. A. (2006). Origins and consequences of centrosome aberrations in human cancers. International Journal of Cancer, 119, 2717-2723.
73. Ganem, N. J., Godinho, S. A., & Pellman, D. (2009). A mechanism linking extra centrosomes to chromosomal instability. Nature, 460, 278-282.
74. Godinho, S. A., Kwon, M., & Pellman, D. (2009). Centrosomes and cancer: how cancer cells divide with too many centrosomes. Cancer and Metastasis Reviews, 28, 85-98.
75. Gisselsson, D., Jin, Y., Lindgren, D., Persson, J., Gisselsson, L., et al. (2010). Generation of trisomies in cancer cells by multipolar mitosis and incomplete cytokinesis. Proceedings of the National Academy of Sciences of the United States of America, 107, 20489-20493.
76. Kwon, M., Godinho, S. A., Chandhok, N. S., Ganem, N. J., Azioune, A., et al. (2008). Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes. Genes & Development, 22, 2189-2203.
77. Fujiwara, T., Bandi, M., Nitta, M., Ivanova, E. V., Bronson, R. T., et al. (2005). Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature, 437, 1043-1047.
78. Ganem, N. J., Storchova, Z., & Pellman, D. (2007). Tetraploidy, aneuploidy and cancer. Current Opinion in Genetics and Development, 17, 157-162.
79. Carter, S. L., Cibulskis, K., Helman, E., McKenna, A., Shen, H., et al. (2012). Absolute quantification of somatic DNA alterations in human cancer. Nature Biotechnology, 30, 413-421.
80. Duncan, A. W., Taylor, M. H., Hickey, R. D., Hanlon Newell, A. E., Lenzi, M. L., et al. (2010). The ploidy conveyor of mature hepatocytes as a source of genetic variation. Nature, 467, 707-710.
81. Duncan, A. W., Hanlon Newell, A. E., Smith, L., Wilson, E. M., Olson, S. B., et al. (2012). Frequent aneuploidy among normal human hepatocytes. Gastroenterology, 142, 25-28.
82. Duncan, A. W., Hanlon Newell, A. E., Bi, W., Finegold, M. J., Olson, S. B., et al. (2012). Aneuploidy as a mechanism for stress-induced liver adaptation. The Journal of Clinical Investigation, 122, 3307-3315.
83. Chen, G., Bradford, W. D., Seidel, C. W., & Li, R. (2012). Hsp90 stress potentiates rapid cellular adaptation through induction of aneuploidy. Nature, 482, 246-250.
84. Albertson, D. G., Collins, C., McCormick, F., & Gray, J. W. (2003). Chromosome aberrations in solid tumors. Nature Genetics, 34, 369-376.
85. Duesberg, P., Rausch, C., Rasnick, D., & Hehlmann, R. (1998). Genetic instability of cancer cells is proportional to their degree of aneuploidy. Proceedings of the National Academy of Sciences of the United States of America, 95, 13692-13697.
86. Gordon, D. J., Resio, B., & Pellman, D. (2012). Causes and consequences of aneuploidy in cancer. Nature Reviews Genetics, 13, 189-203.
87. Weaver, B. A., Silk, A. D., Montagna, C., Verdier-Pinard, P., & Cleveland, D. W. (2007). Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell, 11, 25-36.
88. Aylon, Y., & Oren, M. (2011). p53: guardian of ploidy. Molecular Oncology, 5, 315-323.
89. Olivier, M., Hollstein, M., & Hainaut, P. (2010). TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harbor Perspectives in Biology, 2, a001008.
90. Brown, C. J., Lain, S., Verma, C. S., Fersht, A. R., & Lane, D. P. (2009). Awakening guardian angels: drugging the p53 pathway. Nature Reviews. Cancer, 9, 862-873.
91. Vogelstein, B., Lane, D., & Levine, A. J. (2000). Surfing the p53 network. Nature, 408, 307-310.
92. Horn, H. F., & Vousden, K. H. (2007). Coping with stress: multiple ways to activate p53. Oncogene, 26, 1306-1316.
93. Vousden, K. H., & Lane, D. P. (2007). p53 in health and disease. Nature Reviews Molecular Cell Biology, 8, 275-283.
94. Tang, Y. C., Williams, B. R., Siegel, J. J., & Amon, A. (2011). Identification of aneuploidy-selective antiproliferation compounds. Cell, 144, 499-512.
95. Rehen, S. K., Yung, Y. C., McCreight, M. P., Kaushal, D., Yang, A. H., et al. (2005). Constitutional aneuploidy in the normal human brain. Journal of Neuroscience, 25, 2176-2180.